RMGS PHARMA & AUDITING SERVICES LTD
Company number 14499360 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
RMGS PHARMA & AUDITING SERVICES LTD - Analysis Report
Company Number: 14499360
Analysis Date: 2025-07-20 16:58 UTC
- Credit Opinion: CONDITIONAL APPROVAL
RMGS PHARMA & AUDITING SERVICES LTD is a recently incorporated small private limited company showing modest net assets and working capital. The company demonstrates positive net current assets but with very tight liquidity. The increase in cash from £885 to £26,097 over the last year is a positive sign, but the absence of trade debtors in 2024 (compared to £13,500 in 2023) may indicate changes in revenue recognition or cash collection patterns. Given the early stage of the company and low equity base (£635), credit facilities could be extended with conditions requiring ongoing monitoring of cash flow, debtor management, and timely submissions of accounts. The directors appear stable and have no adverse records.
- Financial Strength:
The balance sheet strength is minimal with net assets of £635 as of 31 October 2024. The company is classified as a small entity with total current assets of £26,097 mainly held as cash, against current liabilities of £25,462. The increase in current liabilities, particularly taxation and social security costs (£24,334), suggests increasing operational scale but also potential cash flow pressures. The share capital remains nominal at £100, with accumulated profits totaling £535, indicating limited retained earnings. The company is solvent but vulnerable to unexpected cash demands.
- Cash Flow Assessment:
Cash position improved substantially from £885 to £26,097 year-on-year, indicating better liquidity management or recent capital injections/fund inflows. However, current liabilities are almost equal to current assets, resulting in very thin net working capital (£635). The lack of reported trade debtors in 2024 could imply faster cash conversion or a reduction in credit sales. The company employs two staff on average, suggesting a lean cost base. The tight liquidity position necessitates close monitoring of cash flows to avoid short-term funding difficulties.
- Monitoring Points:
- Cash flow trends and working capital adequacy, especially given the tight net current assets.
- Credit terms and debtor balances to ensure sustainable revenue recognition and cash inflow.
- Taxation and social security liabilities as they form a significant portion of current liabilities.
- Directors’ adherence to filing deadlines and financial reporting transparency.
- Impact of any business growth or changes in contract terms affecting liquidity and profitability.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.